Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 5,113 shares at $38.94 ($200K) on 2017-11-08, disclosed to the SEC on 2017-11-13.
Open-market sale of $200k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.94 | 2,371 | $92K | 46.2% |
| 2 | $38.94 | 2,371 | $92K | 46.2% |
| 3 | $40.84 | 371 | $15K | 7.6% |
| Total | $39.08 avg | 5,113 | $200K | 100% |
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |